Alexander D., Newcastle disease and other avian Paramyxoviridae infection, In Diseases of Poultry, 10th ed, p 541–569.
Payal Arora, B D Lakhchaura, S K Garg. (2010) Evaluaion of immunogenic potential of 75kDa and 56kDa proteins of newcastle disease virus (NDV). Indian J of Exp Biol. 48, 889-895.
Krishnamurthy S, Huang Z, and Samal SK. (2000) Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology. 278, 168-182
Morgan RW, Gelb Jr J, Schreurs CS, Lütticken D, Rosenberger JK and Sondermeijer PJ. (1992) Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis. 858-870
Nagai Y, Klenk H-D and Rott R. (1976) Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology. 72, 494-508
Gurunathan S, Klinman DM, and Seder RA. (2000) DNA vaccines: immunology, application, and optimization. Immunol. 18, 927-974.
Vijayarani K, Kumanan K, Albert A, Padmanaban VD. (1993) Immunogenicity of Newcastle virus subunits. Indian J Viro. 9,9
Loke C, Omar AR, Raha A, and Yusoff K. (2005) Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet. Immunol. Immunopathol. 106, 259-267
Dortmans JCFM, Guus K, Peter JMR, and Peeters BPH. (2011) Virulence of Newcastle disease virus: what is know so far?J. Vet. Res. 122, 2-11
Allan W and Gough, R. (1974) A standard haemagglutination inhibition test for Newcastle disease.(1). Vet. Rec 1997, 95,120-123.
Stone-Hulslander J and Morrison TG. (1997) Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J. Virol. 71, 6287-6295
Reynolds D and Maraqa A. (2000) Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis. 138-144
Payal Arora, B D Lakhchaura, S K Garg. (2010) Evaluaion of immunogenic potential of 75kDa and 56kDa proteins of newcastle disease virus (NDV). Indian J of Exp Biol. 48, 889-895
Donnelly JJ, Wahren B, and Liu MA. (2005) DNA vaccines: progress and challenges. J. Immunol. 175, 633-639.
Reynolds D and Maraqa A. (2000) Protective immunity against Newcastle disease: the role of cell-mediated immunity. Avian Dis. 145-154.
Reddy GS & Srinivasan VA. (1992) Use of BHK cell culture adapted Newcastle disease virus for immunization of chicks. Vaccine. 10(3),164-6.
Sakaguchi M, Nakamura H, Sonoda K, Hamada F and Hirai K. (1996) Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine. 14, 747-752
Vijayarani K, Kumanan K, Albert A, Padmanaban VD. (1993) Immunogenicity of Newcastle virus subunits. Indian J Viro. 9,9
Jazayeri SD, Ideris A, Zakaria Z, Shameli K, Moeini H, and Omar AR. (2012) Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles. Controlled Release. 161, 116-123
Pedersen N, Hansen S, Heydenreich AV, Kristensen HG and Poulsen HS. (2006) Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur. J. Pharm. Biopharm. 62, 155-162
